Alimera Sciences reported $1.69M in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US $ 4341M 157M
Aerie Pharmaceuticals AERI:US $ 7.9M 1.72M
Alimera Sciences ALIM:US $ 1.69M 0.12M
Bayer BAYN:GR € 3887M 659M
Insmed INSM:US $ 10.18M 654K
Novartis NOVN:VX SF 3848M 94M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M